NF-κB

Biomarker

4 papers1 finding

  • Animals3
  • Cells1

Interventions

1

Silymarin, quercetin and naringenin

downin rats1

1 study
  1. Silymarin, quercetin and naringenin decreases NF-κB in rats.

    “In addition, polyphenolic treatments increased SIRT1 levels and decreased NF-κB levels in hippocampus.”

    AnimalsAged Sprague-Dawley ratshippocampus20 mg/kg/day4 weeksmales

    Chronic Silymarin, Quercetin and Naringenin Treatments Increase Monoamines Synthesis and Hippocampal Sirt1 Levels Improving Cognition in Aged Rats

    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology14 Aug 2017

More on Silymarin, quercetin and naringenin

Funding

2 grants since 2023

National Institute of Allergy and Infectious DiseasesUS$2.6mNational Heart, Lung, and Blood InstituteUS$1.7m

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 2Jul 2026: 4Aug 2026: 27Sep 2026: 29Oct 2026: 468 in 12 months
medRxiv

Estrogen-responsive variants interact with reproductive risk factors

In 13,026 post-menopausal cases and 108,265 controls, an estrogen-responsive polygenic score interacted with reproductive traits including age at first birth (p=0.0052).In 13,026 post-menopausal cases and 108,265 controls, an estrogen-responsive polygenic score interacted with reproductive traits including age at first birth (p=0.0052).

Preprint: case-control study of 108,265 peopleBiomarkers
bioRxiv

Androgen receptor polyglutamine tract controls muscle growth and atrophy pathways

Researchers found that expanding polyglutamine tracts in the androgen receptor shift binding toward senescence-linked enhancers, driving muscle atrophy in cells and mice.Researchers found that expanding polyglutamine tracts in the androgen receptor shift binding toward senescence-linked enhancers, driving muscle atrophy in cells and mice.

Preprint: experiments in human cellsMuscle